Detailed Programme 16-17 September 2008

Tuesday 16 September
07:00-08:30 SYMP Satellite Symposium (Fenix I-III)
Sanofi Pasteur MSD
08:45-10:00 PL02 Plenary 2 (Fenix I-III)

Chair:
  • Dr C.A. Russell
Co-chair:
  • Dr C. Hannoun
Six lectures by the ESWI Young Scientist Award winners
  • Dr C.A. Russell, University of Cambridge, UK: "The Global Circulation of Seasonal Influenza A (H3N2) Viruses"
  • Dr A.C. Lowen, Mount Sinai School of Medicine, USA: "Influenza virus transmission: studies in the guinea pig model"
  • Dr J. Schneider, Robert Koch Instituten Germany: "The nonstructural NS1 protein of influenza B virus interacts with nuclear speckle domains"
  • Dr E.C. Hutchinson, University of Cambridge, UK: "Genetic analysis of cis-acting RNA sequences in influenza A"
  • Dr K.M. Grebe, NIH, USA: "The Sympathetic Nervous System Modulates Anti-Influenza CD8+ T cell Responses in vivo"
  • Dr J.L. McAuley, St Jude Children's Research Hospital, USA: "The 1918 Influenza A Virus PB1-F2 Protein Contributes to the Immunopathogenesis of Viral and Secondary Bacterial Pneumonia"
10:00-10:30   Coffee break
10:30-12:00 SS07 Scientic Session 7 (Fenix I-III)
Antivirals and resistance

Chair:
  • Dr R. Krug, University of Texas, USA
Discussants:
  • Dr W. DeGrado, Department of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, USA: "how his recently published structure of the M2 ion channel protein provides insights for developing new antivirals against this protein."
  • Dr A. Hay, National Institute of Medical Research, UK: "Neuraminidase inhibitors resistance in H1N1"
  • Dr M. Zambon, Health Protection Agency, UK: "Oseltamivir Resistant Influenza A H1N1 Viruses"
  • Dr M. Rameix-Welti, Institut Pasteur, France: "Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir"
  • Dr O. Ferraris, CNRS, France: "Multiple detection of influenza A/H3 viruses lacking the Na gene segment."
  SS08 Scientific Session 8 (Neptuno)
Genetic and antigenic evolution

Chair:
  • Dr N. Cox, Centers for Disease Control and Prevention, USA
Co-chair YS:
  • Dr R. Garten, Influenza Division, Centers for disease control and prevention, USA
Discussants:
  • Dr A. Klimov, Centers for Disease Control and Prevention, USA: "Evolution of Influenza Viruses and Vaccine Strain Selection Process"
  • Dr B. Koel, Department of Virology, Erasmus MC, The Netherlands: "Mapping the molecular determinants of antigenic evolution of the influenza A (H3N2) virus"
  • Dr N. Lewis, University of Cambridge, UK: "The antigenic and genetic evolution of equine influenza virus (h3n8) from 1976 to 2007"
  • Dr J. Bollback, University of Edinburgh, UK: "Reassortment and recombination in influenza"
  • Dr E. Fournier, CNRS, France: "Influenza A packaging control by RNA/RNA interactions: identification of critical domains also controlling genetic reassortment"
  SIP04 Science in Practice 4 (Gemini I-III)
Prepandemic and pandemic vaccination

Chair:
  • Dr D. Smith, University of Cambridge, UK
Discussants (panel discussion):
  • Dr B. Schwartz, National Vaccine Program Office, USA: "Prioritizing pandemic influenza vaccination: public values and public policy."
  • Dr I. Longini, Fred Hutchinson Cancer Research Center, USA: "Strategies for Containing or Slowing the Spread of Pandemic Influenza"
  • Dr A. Osterhaus, Erasmus MC, The Netherlands
12:00-13:30   Lunch
  LUSS01 Lunch Session 1 (Neptuno)
Dr C. Schmaltz, European Commission, Research Directorate General: "How far is it to Brussels? - Your voice in EU research funding for influenza"
  LUSS02 Lunch Session 2 (Neptuno)
Dr J. Serratosa, European Food Safety Authority (EFSA ), Animal Health and Welfare (AHAW): "High Pathogen Avian Influenza: EFSA ’s evaluation of risks in Animal Health"
13:30-15:00 SS09 Scientific Session 9 (Fenix I-III)
Animal flu-ecology

Chair:
  • Dr R. Fouchier, Erasmus MC, The Netherlands
Discussants:
  • Dr. D. Suarez, United States Department of Agriculture, USA: "Avian Influenza in the Live Bird Markets in the U.S."
  • Dr. R. Webster, St. Jude Children’s Research Hospital, USA: "The role of migratory birds in the origin and perpetuation of influenza viruses"
  • Dr. V. Munster, Department of Virlogy, Erasmus MC, The Netherlands: "Avian influenza virus; virus and bird ecology"
  • Dr. I. Brown, Veterinary Laboratory Agency, UK: "Multiple incursions of H5N1 highly pathogenic avian influenza virus in to Europe"
  • Dr. K. Van Reeth, Ghent University, Belgium: "Immunity to H1N1 swine influenza virus can partially protect pigs against a low pathogenic H5N1 avian influenza virus"
  SS10 Scientific Session 10 (Neptuno)
Mathematic modelling

Chair:
  • Dr D. Smith, University of Cambridge, UK
Co-chair YS:
  • Dr W. Alonso, Fogarty International Center- National Institutes Of Health, Florianopolis, Brazil
Discussants:
  • Dr P. Thomas, St.Jude Children’s Research Hospital, USA,: "CD8 T cell epitope recognition: broad detection through a narrow window"
  • Dr I. Longini, Fred Hutchinson Cancer Research Center, USA
  • Dr S. Cauchemez, MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Diseases Epidemiology, Imperal College London, UK: "Estimating the impact of school closure on influenza transmission from Sentinel data"
  • Dr C. Viboud, Fogarty International Center, National Institutes of Health, Bethesda, USA: "Extreme risk of influenza death among young adults: A comparative modeling study of the 1918-20 pandemic in 13 countries"
  • Dr B.J. Cowling, University of Hong Kong, Hong Kong,: "Estimating the serial interval of influenza from natural infections in households"
  SIP05 Science in Practice 5 (Gemini I-III)
Social distancing during a pandemic

Chair:
  • Dr N. Ferguson, University of London, UK
Discussants:
  • Dr N. Ferguson, University of London, UK: "Introduction – lessons from past pandemics"
  • Dr A Nicoll, Influenza Coordinator ECDC, Sweden: "Class Dismissal in Europe During Pandemics – Scientific and Public Health Issues"
  • Dr B. Schwartz, National Vaccine Program Office, USA: "Mitigating secondary consequences of non-pharmaceutical interventions during an influenza pandemic"
15:00-15:30   Coffee break
15:30-17:00 SS11 Scientific Session 11 (Neptuno)
Immunology

Chair:
  • Dr J. Yewdell, National Institute of Allergy and Infectious Diseases, USA
Discussants:
  • Dr G.M. Air, University oif Oklahoma Health Sciences Center, USA: "Antibody quality versus quantity"
  • Dr H. Lu, Inlfuenza Division, NCIRD, CDC, USA: "Influenza A H1N1 neuraminidase antibodies fail to provide cross-protection against lethal challenge with a highly pathogenic avian influenza A H5N1 infection in mice"
  • Dr H. Golding, CBER, FDA, USA: "Analysis of Antibody Repertoires in H5N1 Infected and Vaccinated Individuals using Influenza Whole Genome Phage Display Libraries"
  • Dr G. Rimmelzwaan, Erasmus MC, The Netherlands: "Influenza virus CTL epitopes, remarkably conserved and remarkably variable"
  • Dr J. Yewdell, NIAID, NIH, USA: "tRNA Misacylation: A novel Innate Immune Response to Viruses – CTLs, Misacylation, and Supercoding"
  SS12 Scientific Session 12 (Fenix I-III)
Vaccine evaluation

Chair:
  • Chair: Dr J. Wood, National Institute for Biological Standards and Control, UK
Co-chair YS:
  • Dr J.C. Kwong, Institute For Clinical Evaluative Sciences, Toronto, Canada
Discussants:
  • Dr J. Wood, National Institute for Biological Standards and Control, UK: "New challenges for influenza vaccine development"
  • Dr D. Skowronski, BC Center for Disease Control, Canada: "Component-specific efficacy of trivalent influenza vaccine: sentinel surveillance to detect virus variation and impact on protection"
  • Dr D. Shay, CDC, USA: "Multi-state Case-control Study of the Effectiveness of Influenza Vaccine in Preventing Laboratory-confirmed Influenza Hospitalizations among Children Aged 6-23 months during the 2005-06 and 2006-07 Seasons"
  • Dr J.C. Kwong, Institute for Clinical Evaluative Sciences, Canada: "The effect of universal influenza immunization on mortality and health care use"
  • Dr N. Sugaya, Keiyu Hospital, Japan: "Mass Vaccination of Schoolchildren and Influenza Outbreaks in a School"
  SIP06 Science in Practice 6 (Gemini I-III)
Equitable availability of intervention strategies in a pandemic

Chair:
  • Chair: Dr K. Fukuda, World Health Organisation, Switzerland
Discussants:
  • Dr A. Nicoll, ECDC, Sweden: "Where are we now and what needs to be done – pandemic countermeasure in Europe"
  • Dr S. Jadhav, President - DCVMN & Executive Director - Serum Institute of India: "Pandemic flu vaccine preparedness : Developing Countries Vaccine Manufacturers' perspective"
  • Dr L. Hessel, Chairman, Influenza Pandemic Working Group, European Vaccine Manufacturers: " The industry contribution to the equitable availability of vaccines in a pandemic situation"
  • Dr D. Reddy, Pandemic Influenza Taskforce Leader, F.Hoffmann-La Roche Ltd, Switzerland: "Access to antiviral stockpiles for pandemic use – an industry perspective"
17:00-18:00   Poster Session 2 (Blue Corner)
18:00-19:30 SYMP Satellite Symposium (Fenix I-III)
Novartis
20:30-23:00   ESWI Aniversary Dinner

Wednesday 17 September
07:00-08:30 SYMP Satellite Symposium (Fenix I-III)
Sanofi Pasteur
08:45-10:00 PL03 Plenary 3 (Fenix I-III)
Keynote lectures by
  • Dr M. Peiris, University of Hong Kong, Hong Kong
  • Dr D. Swayne, USDA/Agricultural Research Service, USA - "Strategies and Challenges to the Development and Application of Avian Influenza Vaccines in Birds"
10:00-10:30   Coffee break
10:30-12:00 PL04 Plenary 4 (Fenix I-III)
Pandemic preparedness

Chair:
  • Dr K. Fukuda, World Health Organisation, Switzerland
Co-chair:
  • Dr K. Ekdahl, ECDC, Sweden
Discussants:
  • Dr J. Katz, Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA: "Assessing the Pandemic Risk of Avian Influenza Viruses"
  • Dr N. Ferguson, University of London, UK: "Predicting the impact of layered interventionist"
  • Dr J. Van-Tam, University of Nottingham, UK
  • Dr J. Watkins, University of Wales, UK: "Pandemic Planning at a Sub-National Level"
12:00-12:30   Closing Session (Fenix I-III)
  • Keynote lecture by Dr A. Osterhaus, Erasmus MC, The Netherlands
  • Awards to young scientists
13:00-14:00   Lunch